Security key
98973P309
Alaunos Therapeutics, Inc. - Common stock (TCRT)
CUSIP: 98973P309
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common stock
- Shares outstanding
- 2,198,384
- Total 13F shares
- 70,134
- Share change
- -1,074
- Total reported value
- $102,359
- Price per share
- $1.47
- Number of holders
- 25
- Value change
- -$2,277
- Number of buys
- 6
- Number of sells
- 7
Report period
Q1 2025
Institutions
25
Top holders
10
TCRT full security history
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Alaunos Therapeutics, Inc. SEC filings
Alaunos Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98973P309
Recent filing periods:
Top shareholders of TCRT - Alaunos Therapeutics, Inc. - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Kevin S. Boyle Sr. |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
798,236
|
$111,993 | — | 01 Sep 2023 | |
| BlackRock, Inc. |
13F
|
Company |
0.97%
|
21,353
|
$40,677 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.95%
|
20,972
|
$39,847 | — | 31 Dec 2024 | |
| Raffaele Baffa |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
280,645
|
$39,374 | — | 17 May 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
15,216
|
$28,918 | — | 31 Dec 2024 | |
| Heidi Hagen |
3/4/5
|
Director |
—
class O/S missing
|
145,889
|
$20,468 | — | 02 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.36%
|
7,869
|
$14,990 | — | 31 Dec 2024 | |
| Christopher Bowden |
3/4/5
|
Director |
—
mixed-class rows
|
144,167
mixed-class rows
|
$6,197 | — | 22 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0.07%
|
1,597
|
$3,034 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.05%
|
1,149
|
$2,189 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
1,046
|
$1,992 | — | 31 Dec 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.04%
|
860
|
$1,632 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.02%
|
343
|
$652 | — | 31 Dec 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
300
|
$570 | — | 31 Dec 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
300
|
$555 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
277
|
$528 | — | 31 Dec 2024 | |
| Sugarloaf Wealth Management, LLC |
13F
|
Company |
0.01%
|
169
|
$322 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
138
|
$263 | — | 31 Dec 2024 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
98
|
$187 | — | 31 Dec 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
82
|
$156 | — | 31 Dec 2024 | |
| Na Bokf |
13F
|
Individual |
0%
|
66
|
$112 | — | 31 Dec 2024 | |
| Asset Dedication, LLC |
13F
|
Company |
0%
|
54
|
$103 | — | 31 Dec 2024 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0%
|
24
|
$46 | — | 31 Dec 2024 | |
| SIGNATUREFD, LLC |
13F
|
Company |
0%
|
23
|
$44 | — | 31 Dec 2024 | |
| THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. |
13F
|
Company |
0%
|
21
|
$40 | — | 31 Dec 2024 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0%
|
19
|
$36 | — | 31 Dec 2024 | |
| Sunbelt Securities, Inc. |
13F
|
Company |
0%
|
10
|
$22 | — | 31 Dec 2024 | |
| WEST PACES ADVISORS INC. |
13F
|
Company |
0%
|
10
|
$19 | — | 31 Dec 2024 | |
| MAI Capital Management |
13F
|
Company |
0%
|
6
|
$12 | — | 31 Dec 2024 | |
| PSI Advisors, LLC |
13F
|
Company |
0%
|
6
|
$11 | — | 31 Dec 2024 | |
| Sugar Maple Asset Management, LLC |
13F
|
Company |
0%
|
6
|
$11 | — | 31 Dec 2024 | |
| TUCKER ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Dec 2024 | |
| Eleanor de Groot |
3/4/5
|
EVP, Operations |
—
class O/S missing
|
350,000
|
— | — | 30 Mar 2022 | |
| Abhishek K. Srivastava |
3/4/5
|
Vice President, Technical Operations |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| Drew Deniger |
3/4/5
|
Vice President, Research and Development |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| Michael Wong |
3/4/5
|
Vice President, Finance |
—
class O/S missing
|
125,000
|
— | — | 15 Mar 2023 | |
| James Huang |
3/4/5
|
Director |
—
class O/S missing
|
100,000
|
— | — | 06 Jun 2023 | |
| Mary Thistle |
3/4/5
|
Director |
—
class O/S missing
|
100,000
|
— | — | 06 Jun 2023 | |
| Robert Hofmeister |
3/4/5
|
Director |
—
class O/S missing
|
12,800
|
— | — | 06 Jun 2024 | |
| Dale Curtis Hogue Jr. |
3/4/5
|
Chief Executive Officer, Interim, Director |
—
class O/S missing
|
3,000
|
— | — | 29 Mar 2025 | |
| Melinda Lackey |
3/4/5
|
Legal & Administration |
—
class O/S missing
|
1,000
|
— | — | 29 Mar 2025 |
Institutional Holders of Alaunos Therapeutics, Inc. - Common stock (TCRT) as of Q1 2025
As of 31 Mar 2025,
Alaunos Therapeutics, Inc. - Common stock (TCRT) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,134 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC), MORGAN STANLEY, OSAIC HOLDINGS, INC., GROUP ONE TRADING LLC, WELLS FARGO & COMPANY/MN, and BARCLAYS PLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
28
Q1 2025 holders
25
Holder diff
-3
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.